0001170316-24-000002.txt : 20240116
0001170316-24-000002.hdr.sgml : 20240116
20240116114520
ACCESSION NUMBER: 0001170316-24-000002
CONFORMED SUBMISSION TYPE: SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240116
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Verve Therapeutics, Inc.
CENTRAL INDEX KEY: 0001840574
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 824800132
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-92605
FILM NUMBER: 24534251
BUSINESS ADDRESS:
STREET 1: 201 BROOKLINE AVENUE
STREET 2: SUITE 601
CITY: BOSTON
STATE: MA
ZIP: 02215
BUSINESS PHONE: (978) 501-3026
MAIL ADDRESS:
STREET 1: 201 BROOKLINE AVENUE
STREET 2: SUITE 601
CITY: BOSTON
STATE: MA
ZIP: 02215
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: SINGER JAMES R
CENTRAL INDEX KEY: 0001170316
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: SCHEDULE 13G/A
MAIL ADDRESS:
STREET 1: PO BOX 1395
CITY: YARMOUTH
STATE: ME
ZIP: 04096
SCHEDULE 13G/A
1
primary_doc.xml
SCHEDULE 13G/A
0001170316-22-000004
0001170316
XXXXXXXX
LIVE
2
Common Stock
12/31/2023
0001840574
Verve Therapeutics, Inc.
92539P101
201 BROOKLINE AVENUE
201 BROOKLINE AVENUE
BOSTON
MA
02215
Rule 13d-1(c)
SINGER JAMES R
ME
3000000.00
0.00
3000000.00
0.00
3000000.00
3.7
IN
Verve Therapeutics, Inc.
201 BROOKLINE AVENUE, 201 BROOKLINE AVENUE, BOSTON, MASSACHUSETTS, 02215.
James R. Singer
P.O. Box 1395, Yarmouth, ME 04096
United States of America
Y
3,000,000.00
3.7
3,000,000.00
0.00
3,000,000.00
0.00
N
Y
Y
Y
Y
Y
N
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SINGER JAMES R
James R. Singer
Individual
01/16/2024